Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is a biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food, and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride, and Xprecia Prime, which are medical devices; Sentia non-medical wine testing products, and Petrackr, which is a blood glucose test used in cats and dogs. It has one reportable segment: a specialist biosensors company. Geographically, the company generates the majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
76
Stocks News & Analysis
stocks
Strong guidance from undervalued ASX share
stocks
TSMC earnings: Refining guidance and expansion plans amid strong AI demand
stocks
Unconventional wisdom: A top performing ‘AI share’ accidently ended up in my portfolio
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,155.90 | 20.20 | 0.22% |
| CAC 40 | 8,262.70 | 11.87 | -0.14% |
| DAX 40 | 24,154.47 | 87.77 | 0.36% |
| Dow JONES (US) | 48,578.72 | 115.00 | 0.24% |
| FTSE 100 | 10,589.99 | 30.41 | 0.29% |
| HKSE | 26,046.70 | 347.56 | -1.32% |
| NASDAQ | 24,102.70 | 86.69 | 0.36% |
| Nikkei 225 | 58,994.41 | 523.93 | -0.88% |
| NZX 50 Index | 12,962.32 | 103.74 | -0.79% |
| S&P 500 | 7,041.28 | 18.33 | 0.26% |
| S&P/ASX 200 | 8,935.90 | 25.80 | 0.29% |
| SSE Composite Index | 4,043.45 | 12.10 | -0.30% |